Redesign Health launches growth equity practice for clinical AI

Nov 13, 2026
The healthcare investor will make minority investments from Series A to pre-IPO in health IT, AI-enabled services and clinical AI.

Redesign Health has launched a Growth Equity practice to make minority investments in healthcare companies from Series A through pre-IPO, focusing on healthcare IT, AI-enabled services and clinical AI, the firm announced.

Redesign Health, founded in 2018, has already made growth-stage bets such as Hippocratic AI. "Growth Equity expands our ability to back exceptional companies at pivotal points in their development," said CEO Brett Shaheen. The new practice targets companies with customers, revenue and product-market fit, alongside the firm's seed investing and its venture buyouts, where it takes control of established businesses and applies AI to their operations.

We hope you enjoyed this article

Free newsletter

Enterprise AI Brief

Weekly report on AI business applications, enterprise software releases, automation tools, and industry implementations.

Guide
AI meeting notetakers for workplace conversations

AI meeting notetakers for workplace conversations

A guide to capture methods, meeting notes and team workflows

Industry analysis

2025 Global Business Services Agenda: Gen AI Takes Center Stage

The Hackett Group

This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.

Read more

You may also like

Free, six days a week

Daily AI Brief: the AI news that matters, in your inbox.